1. Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma. Issue 1 (December 2016) Authors: Divitiis, C.; Arx, C.; Grimaldi, A.; Cicala, D.; Tatangelo, F.; Arcella, A.; Romano, G.; Simeone, E.; Iaffaioli, R.; Ascierto, P.; Tafuto, S. Journal: Journal of translational medicine Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Peripheral myeloid-derived suppressor and t-regulatory pd-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients. Issue 10 (October 2016) Authors: Cardone, E.; Napolitano, M.; Rega, D.; Tatangelo, F.; Scala, D.; Delrio, P. Journal: European journal of surgical oncology Issue: Volume 42:Issue 10(2016:Oct.) Page Start: S202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗